baber/WOPTO huggingface dataset:
Patent CA-2536427-A1 (CA)
Inventor: QI YIHONG
IPC: H04Q7/32
Filed: 2006-02-27
Abstract: A mobile wireless communications device may include a portable handheld housing, and a wireless transceiver carried by the housing. A pair of an antennas are positioned in side-by-side relation preferably in the upper portion of the portable handheld housing. A human interface diversity controller is connected to the wireless transceiver to preferentially operate with the plurality of antennas based upon a relative position of the portable handheld housing with respect to a hand of a human user. The device can select or weight the antennas based upon the position of the device when being held by a user.
Patent CA-2539456-A1 (CA)
Inventor: DESPINS MAURICE
IPC: A47G27/02
Filed: 2006-03-14
Abstract: A carpet having directional guide markings is provided for orienting the carpet with respect to machine direction. The carpet includes an upper surface and a lower surface visible from the bottom side of the carpet. The fabric carpet backing includes a plurality of linear patterns visible on the lower surface running generally perpendicular to the machine direction from one edge of the carpet to the other. The linear patterns can include a line of text or can include at least first and second linear sub-patterns that are visually distinct from one another. As a result, a directional guide is provided by these linear patterns for orienting the carpet with respect to its machine direction and from left to right even if the carpet is cut along its machine direction.
Patent CA-2542173-A1 (CA)
Title: System and method for application balanced scorecard optimizer
Inventor: KINGDON RAYMOND A
IPC: G06Q99/00
Filed: 2006-04-06
Abstract: There disclosed a system and method for managing an application portfolio. In an embodiment, a system is designed to provide a balanced, cohesive, end-to-end approach to application portfolio management. Taking into account a number of decision drivers for application portfolio management (e.g. business drivers, technology drivers, financial drivers, and staffing/labour drivers), the system attempts to process this information, using one or more fuzzy logic algorithms derived from one or more expert knowledge bases, into an actionable implementation plan and business case. Upon validation of the implementation plan and business case, one or more of the expert knowledge bases may be updated with additional expert knowledge.
Patent CA-2544365-A1 (CA)
Title: Modified anti-cd52 antibody
Inventor: HAMILTON ANITA A
IPC: C12N5/06
Filed: 2004-10-29
Abstract: The present invention provides for modified forms of anti-CD52 antibodies with reduced numbers of potential T-cell epitopes that are expected to display decreased immunogenicity.
Patent CA-2552323-A1 (CA)
Title: Buoyant container with wave generated power production
Inventor: HAVELKA STEVEN E
IPC: H04B1/02
Filed: 2005-01-28
Abstract: An apparatus designed to float on or in a liquid has at least two buoyant members. The apparatus utilizes relative motion between the buoyant members to generate power, and the buoyant members are coupled to the apparatus in such a manner that surface movement of a fluid that the apparatus is floating in causes relative motion between the buoyant members. The apparatus may be a housing that includes an electrical apparatus within it, with the electrical apparatus being powered directly or indirectly by power generated by the floating apparatus. The apparatus may be a sonobuoy, and may include a sensor array hanging from a floating housing that includes the at least two buoyant members.
Patent CA-2556086-A1 (CA)
Inventor: KAUTZ ULRICH
IPC: A61P37/02
Filed: 2005-02-17
Abstract: Compounds of a certain formula (1), in which R1, R2, R3, R31, R4, R5, R6 and R7 have the meanings indicated in the description, are novel effective PDE4 inhibitors in which R7 is a radical of formulae (a), (b), (c) or (d).
Patent CA-2556104-A1 (CA)
Title: Diagnosis or treatment of endothelial cell dysfunction related diseases
Inventor: ROMEO GUILIO
IPC: C07K14/00
Filed: 2005-02-22
Abstract: The present invention provides a method of determining the disease state of a disease or condition associated with EC dysfunction in a subject. An exemplary method screens for elevated profilin-1 levels as a marker for DVD and other vascular diseases such as atherosclerosis, cerebrovascular disease, CVD or peripheral vascular disease. The invention also provides a method for the prophylaxis or treatment of such diseases or conditions associated with EC  dysfunction. The method comprises administering to a subject a therapeutic composition or carrying out a protocol to inhibit the activity or function of profilin-1. In an embodiment, the composition comprises an inhibitor of profilin-1 activity or function administered in a pharmaceutically acceptable carrier. The therapeutic protocol or method can, for instance, be siRNA based or a strategy for gene therapy. The invention further provides a kit that can be used to carry out a diagnostic method.
Patent CA-2556332-A1 (CA)
Title: Siding element for creating structured facades of buildings
Inventor: CONRADI ULRICH
IPC: E04F13/18
Filed: 2006-08-17
Abstract: A siding element for creating a facade of building constructions includes a substantially slablike element having a protrusion with a two-dimensional surface, which in cross section protrudes at least out of the plane of the slablike element.
Patent CA-2557581-A1 (CA)
Title: Inhibitors of dna methylation in tumor cells
Inventor: LYKO FRANK
IPC: C07D471/04
Filed: 2005-03-08
Abstract: The present invention relates to compounds according to the general formula (I) wherein the dotted lines denote a single bond which is optionally present, with 2 dotted lines denoting a double bond; wherein, in case no double bond is present and a free valence exists, this valence is occupied by H; and wherein the symbols in particular have the following meanings: R1 and R2 are independently from each other selected from the group consisting of: H; OH;  (=O); halogens; pseudohalogens;. NH2; S(O)mR5; SO2NH2 ; C(O)R8; C(O)OR9;  CONH2; C1-C2-alkyl susbtituted by NH2, OH, S(O)mR5, SO2NH2, C(O)R8, C(O)OR9, CONH2; C1-C2-alkoxy substituted by NH2, OH, S(O)mR5, SO2NH2, C(O)R8, C(O)OR9, CONH2; Ar denotes an unsubstituted mononuclear aryl group having 6 or 7 members, which aryl group is annulated to the neighbouring 5-membered cycle, and which may carry 1, 2 or 3 heteroatoms from the group N, O and S in its cycle; Y, Z denote independently from each other a nitrogen atom or a methylene group; X is a nitrogen atom or a methylene group; A is selected from the group consisting of: H; halogens and pseudohalogens; OH; =N(OH); NR12R13;  OSO3- ; S(O)mR14; SO2NR15 R16 ; C(O)R17; C(O)OR18; CONR19R20; C(S)R21, C(S)OR22; unsubstituted and at least monosubstituted C1-C6-alkyl which can carry in its chain one or more non-adjacent heteroatoms from the group nitrogen and oxygen. These compounds are used as inhibitors of DNA methylation and therefore useful in the treatment of various forms of cancer.
Patent CA-2557653-A1 (CA)
Inventor: FERGUSON SCOTT
IPC: A63F13/12
Filed: 2004-08-16
Abstract: Amusement device communication system (10) includes a communication link (12), a first amusement device (14) and a second amusement device (16). The communication link (12) has a communication medium (13) and a power line communication subsystem. The first amusement device (14) has a video touchscreen (15a), and the second amusement device (16) has a controller (U3) and a memory (U4). The second amusement device (16) is coupled to the first amusement device (14) by the communication link (12), and the first amusement device (14) communicates with the second amusement device (16) using the communication medium (13). The power line communication sub-system (111) includes a local power grid (109) and first and second power line adapters (118, 120). The local power grid (109) is configured to supply electrical power to local devices. The first power line adapter (118) is coupled between the first amusement device (14) and the local power grid (109). The first adapter (118) superimposes communication signals onto the local power grid (109) and decodes superimposed communication signals from the local power grid (109).
Patent CA-2560009-A1 (CA)
Inventor: BRODKE DARREL
IPC: A61F2/30
Filed: 2005-02-10
Abstract: A bone screw (10) is provided having a head (12) and a shank (14) with opposed first and second (16, 18) helical threads extending there around. In one embodiment, the shank (14) has a proximal portion (14p) with a constant minor diameter (d1), and a distal portion (14d) with a minor diameter (d2) that decreases in a proximal-to-distal direction to form a taper. The opposed first and second helical threads (16, 18) preferably define a thread depth (dt) that remains constant along the length of the shank (14). In an exemplary embodiment, a major diameter (D2) of the shank (14) at a distal tip of the shank (14) is equal to or less than the minor diameter (d1) of the proximal portion of the shank (14).
Patent CA-2561425-A1 (CA)
Title: High chromium ferritic steel with 0.5 atomic % hafnium, part of which is ion implanted
Inventor: FAULKNER ROY
IPC: C23C14/48
Filed: 2005-04-01
Abstract: The application relates to the problem of improving the corrosion resistance and creep properties of standard Cr-steels like E911 (table 1) at high temperatures. To solve this problem, a method of adding up to 0.5 atomic % Hf both during casting or moulding and by ion implantation is provided. The addition of Hf improves the corrosion resistance and creep properties inter alia, as it forms a finely distributed stable second phase and as the harmful M23C6 disappears, because all carbon is taken by Hf to form HfC.
Patent CA-2561831-A1 (CA)
Title: Polycyclic pyrazines as potassium ion channel modulators
Inventor: SUZUKI TAKESHI
IPC: C07D401/14
Filed: 2005-04-13
Abstract: The present invention provides a genus of polycyclic pyrazines of formula I  (I) that are useful as modulators of potassium ion channels. The modulators of the invention are of use in both therapeutic and diagnostic methods; wherein A  and B are independently substituted or unsubstituted 5- or 6-membered heterocycloalkyl, or substituted or unsubstituted 5- or 6- membered heteroaryl, W1 is formula II (II); W2 is -CH=, -NH-, -N=, -S-, or -O-; Z1 is formula III (III) or formula IV (IV); Z2 is -CH=, -NH-, -N=, -S-, or -O-; Y is a bond, -CH=N-NH-, -NH-CH2-, or -NR5-; s and t are independently integers from 1 to 4; R1, R2A, R2B and R3 are independently or unsubstituted alkyle, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted 3- to 7- membered cycloalkyl,, substituted or unsubstituted 5- to 7-membered heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; and R5 is H, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted 3- to 7- membered cycloalkyl,, substituted or unsubstituted 5-to 7-membered heterocycloalkyl, substituted or unsubstituted aryl or substituted or unsubstituted heteroaryl; wherein if s is greater than one, then each R1 is optionally different; wherein if t is greater than on, then each R3 is optionally different; wherein two R1 groups are optionally joined together with the atoms to which they are attached to form a substituted or unsubstituted ring; and wherein two R3 groups are optionally joined together with the atoms to which they are attached to form a susbtituted or unsubstituted ring.
Patent CA-2562138-A1 (CA)
Title: Fused ring nk1 antagonists
Inventor: WANG CHENG
IPC: A61K31/4375
Filed: 2005-04-06
Abstract: A compound having the general structure shown in Formula (1) or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK1 receptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough.
Patent CA-2564815-A1 (CA)
Title: Composite marine riser
Inventor: HUMPHREYS GAVIN
IPC: E21B17/01
Filed: 2005-04-22
Abstract: A composite marine riser (22) may be formed, in one embodiment, of a pair of threaded metallic sections (115,118) having threaded external surfaces (138,140). The threaded external surfaces may taper from a larger to a smaller diameter. The composite material (120) may be formed over the threaded external surfaces, which surfaces serve to transfer force from the metallic sections to the composite material.
Patent CA-2565304-A1 (CA)
Inventor: MAKOWAN TED J
IPC: F16K24/04
Filed: 2006-10-24
Abstract: A two-way damper is provided including a retaining member and a baffle. The baffle comprises a flexible member with a first portion secured and held in a fixed position by the retaining member and a second portion normally oriented in a first position, but free to move relative to said first position. The baffle also comprises a third portion, arranged between the first and second portions, being flexible and resilient and allowing the second portion to move to a second position relative to the first position upon the application of a pressure differential across the baffle above a threshold pressure and causing the second portion to return to the first position upon the application of a pressure differential across the baffle below the threshold pressure.
Patent CA-2565319-A1 (CA)
Title: Stable and water-soluble plant growth regulator liquid compositions and methods for use of same
Inventor: LOPEZ JOHN
IPC: A01N47/36
Filed: 2005-05-23
Abstract: Soluble and stable liquid compositions containing a plant growth regulator selected from the group consisting of cytokinin and a gibberellin, an acid solubilizer such as citric acid, tartaric acid or glycolic acid and a solvent;  as well as methods for making and using the composition are disclosed. The compositions improve solubility, handling, stability, safety, as well as activity improvements such as improved plant growth, yield, fruit thinning or sizing and quality. The compositions are soluble and stable by adding an ethoxylated alkyl alcohol wherein the growth regulator is 6-benzyladenine (6-BA) or forchlorfenuron (CPPU) and the ethoxylated alcohol surfactant is C12-15 alkyl alcohol in propylene glycol. The compositions may also contain a cytokinin such as 6-benzyladenine (6-BA) or forchlorfenuron (CPPU) that is increased in solubility and activity and by synergistically combined with GA3 or GA4A7 as well as in storage stability by adding an antioxidant. The compositions are formulated in a ready-to-mix formulation.
Patent CA-2566553-A1 (CA)
Title: System and method for therapy and diagnosis comprising optical components for distribution of radiation
Inventor: SVANBERG SUNE
IPC: A61B17/00
Filed: 2004-05-14
Abstract: A system and method for interactive therapy and diagnosis of a human or animal comprising at least one first radiation source for emission of a diagnostic radiation, at least one second radiation source for emission of a therapeutic radiation, and at least one radiation conductor adapted to conduct radiation to a tumour site at or in said human or animal. A non-mechanical operation mode selector directs the therapeutic radiation and/or the diagnostic radiation to the tumour site through the radiation conductors. The operation mode selector means is preferably a non-mechanical optical switch and/or an optical combiner. The system may be used for interactive interstitial photodynamic tumour therapy.
Patent CA-2567470-A1 (CA)
Title: Prouroguanylin as therapeutic and diagnostic agents
Inventor: GOY MICHAEL F
IPC: A61K38/00
Filed: 2005-05-16
Abstract: A method for treating a disorder characterized by salt retention, fluid retention, and combinations thereof. A method for determining the presence of or the progression of a disorder characterized by salt retention, fluid retention, salt loss, fluid loss, and combinations thereof. An immunoassay kit for detecting a level of prouroguanylin in a sample.
Patent CA-2567983-A1 (CA)
Title: Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
Inventor: NADZAN GREG
IPC: A01H5/00
Filed: 2005-05-27
Abstract: Published without an Abstract
Patent CA-2568480-A1 (CA)
Inventor: RICHARDSON LUKE EDWARD
IPC: G01N21/78
Filed: 2006-11-22
Abstract: A process and apparatus for sensing gas concentration in a gas stream involves producing a succession of difference values representing differences between successive sample values of a succession of sample values representing instantaneous reflectance of light from a compound produced by reacting a reagent with the gas being sensed and producing a gas concentration value in response to a maximum difference value of the succession of difference values.
Patent CA-2570887-A1 (CA)
Inventor: POLAKIS PAUL
IPC: A61K31/4745
Filed: 2005-06-17
Abstract: The invention concerns an improved method for treating tumor, including cancer, which combines the administration of a chemotherapeutic agent and an antagonist of a gene product the expression of which is upregulated by the chemotherapeutic agent. The invention further concerns methods and means for the diagnosis and classification of tumors, and for the prognosis of the outcome of tumor treatment, and patient response to a particular treatment modality.
Patent CA-2570895-A1 (CA)
Title: Compound metal analyte sensor
Inventor: SASS RICHARD G
IPC: A61B5/1468
Filed: 2004-06-16
Abstract: A sensing element (12) adapted to, at least in part, be inserted into a mammalian body. The sensing element (12) is made up of a core of a structurally robust metal (24) and a plated portion made of an electrochemically active metal (26) conjoined to at least a portion of the core (24). This sensing element (12) may be used as part of a method for the continuous monitoring of analyte within a mammalian body. The method includes inserting at least a portion of sensing element (12) into the mammalian body and measuring any electric current produced by at least of portion of the Sensor (12).
Patent CA-2571916-A1 (CA)
Inventor: FOLEY PETER F
IPC: B01J8/00
Filed: 2005-06-14
Abstract: An autothermal reformer or a catalytic partial oxidizer (19) receives flow of desulfurized hydrocarbon fuel from a hydrogen desulfurizer (HDS) (15) through an orifice (13a). A differential pressure transducer (13b) provides a signal (24a) to a fuel-flow differential-pressure schedule (13c) to provide a fuel flow signal (24b) which is (25) subtracted from fuel command (26), to provide a valve position signal 30a from a proportional/integral gain (29), being linearized (58) to control the fuel valve (12). The minimum (59) of actual fuel flow (24b) and fuel flow command (59) is applied to an air/fuel schedule (33). The resulting air flow command is compared with actual air flow (41b) to provide an air flow control signal 48a which is linearized (60) after proportional/integral gain (47) to provide air flow command (48b) to a blower (49). Differential pressure (42b) across an orifice (42a) is provided to a schedule (42c) which converts to the actual air flow feedback (4lb). A laminar flow restriction (42b) may be warmed by a CPO (19).
Patent CA-2572802-A1 (CA)
Inventor: PAN YU-CHING EUGENE
IPC: C07K16/24
Filed: 1990-12-19
Abstract: The present invention relates to a novel cytokine protein called Cytotoxic Lymphocyte Maturation Factor (CLMF) which is produced and synthesized by a human B lymphoblastoid cell line. CLMF synergistically induces in the presence of low concentrations of IL-2 the cytolytic activity of Lymphokine Activated Killer (LAK) cells. CLMF is also capable of stimulating T-cell growth. The present invention also relates to cloned genes coding for CLMF proteins and derivatives thereof, to recombinant vectors comprising a polynucleotide encoding a CLMF protein, to microorganisms transformed with the said recombinant vectors, to antibodies directed to the said proteins as well as to processes for the preparation of the said proteins, vectors and antibodies. Furthermore the present invention relates to methods for stimulating LAK cells, T-cells or Natural Killer Cells using the said CLMF protein.
Patent CA-2574926-A1 (CA)
Title: 1,1,2,2-tetra(hetero)arylethanes or 1,1,2-tri(hetero)aryl-2-heterocyclylethanes as potassium channel inhibitors
Inventor: DINSMORE CHRISTOPHER J
IPC: A61K31/44
Filed: 2005-07-25
Abstract: The present invention relates to compounds having the structure useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like.
Patent CA-2579228-A1 (CA)
Title: Hydroprocessing catalyst with zeolite and high mesoporosity
Inventor: ANGEVINE PHILIP J
IPC: B01J21/08
Filed: 2005-09-07
Abstract: A catalyst for hydrocarbon conversion includes at least the following three components (1) at least one element with a hydrogenation function, (2) at least one type of microporous zeolite, and (3) a porous, noncrystalline inorganic oxide having randomly interconnected mesopores and having an X-ray reflection in 20 between 0.5 degrees to 2.5 degrees.
Patent CA-2579634-A1 (CA)
Inventor: KIKUI FUMIAKI
IPC: C23C14/16
Filed: 2005-09-08
Abstract: L~invention porte sur un séparateur à pile à combustible d~une excellente résistance à la corrosion et d~une excellente conductivité. Le séparateur à pile à combustible est pourvu d~un matériau de base (1) réalisé en acier contenant un Cr d~une teneur supérieure ou égale à 10,5 % en masse, un film métallique (3) formé à la surface du matériau de base (1) et une couche intermédiaire (2) contenant de l~oxygène formée entre le matériau de base (1) et le film métallique (3). Le film métallique (3) est composé de Au ou de Pt, et la couche intermédiaire (2) comporte du Fe et du Cr contenus dans l~acier, de même que du Au ou du Pt constituant le film métallique (3).
Patent CA-2580030-A1 (CA)
Title: Dynamic firewall capabilities for wireless access gateways
Inventor: BORELLA MICHAEL
IPC: G06F15/16
Filed: 2005-09-08
Abstract: The present invention provides a method and system for dynamic filtering of data packets at an access gateway in a communication network. According to the method, a policy server receives a request for registration with the network from a network node. The server verifies the network node identity and selects the corresponding security policy for the network node. The selected security policy is indicated by the server to a network access gateway. The network access gateway selects the indicted security policy. The selected security policy is applied for the communication between the network node and the network.
Patent CA-2580392-A1 (CA)
Title: Anti-cavitation valve assembly
Inventor: FOLK ROBERT
IPC: F16K47/08
Filed: 2005-09-22
Abstract: A valve assembly for reducing cavitation includes a seat disposed within a valve housing intermediate a fluid inlet and outlet thereof. A disc guide is associated with the seat so as to be slidably moveable relative to the seat.  The seat includes a wall defining an inner-chamber and having elongated slots formed therein so as to direct fluid towards a central portion of the fluid chamber. The disc guide includes a wall having elongated slots formed on an upper portion thereof, and a non-slotted lower portion configured to substantially occlude the elongated slots of the seat when the disc guide is moved into a closed position.
Patent CA-2581517-A1 (CA)
Title: Compound offset handle
Inventor: BASTIAN ADAM
IPC: A61B17/00
Filed: 2007-03-06
Abstract: A device for use on a patient during surgery including a distal portion, a transition portion, and a proximal portion is disclosed. The distal portion is adapted to attach to an implement having a proximal portion. The transition portion is angled toward an anterior direction and a medial direction with respect to the implement, the proximal portion of the handle being connected to the transition portion and extending in a proximal direction substantially parallel to the implement.